Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.

The American journal of tropical medicine and hygiene - 1 Oct 2017

Weppelmann Thomas A, von Fricken Michael E, Wilfong Tara D, Aguenza Elisa, Philippe Taina T, Okech Bernard A

Abstract excerpt

Throughout many developing and tropical countries around the world, malaria remains a significant threat to human health. One barrier to malaria elimination is the ability to safely administer primaquine chemotherapy for the radical cure of malaria infections in populations with a high prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency. In the current study, a field trial of the world's first...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antimalarials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biosensing Techniques

Share to Glucosephosphate Dehydrogenase

Share to Malaria

Share to Point-of-Care Systems

Source

Open in PubMed Open full text

Identifiers

PMID: 28820691
DOI: 10.4269/ajtmh.16-0714
PMCID: PMC5637584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.PMID 28820691Read ↗

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.Semantic proximity Read ↗

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity Read ↗

Clinical Performance of the STANDARD™ G6PD Test in IndiaSemantic proximity Read ↗

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity Read ↗

Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti.Semantic proximity Read ↗

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.Semantic proximity Read ↗

Assessment of Glucose-6 phosphate dehydrogenase deficiency in malaria suspected patients attending at Shele and Lante Health Center, Southern EthiopiaSemantic proximity Read ↗

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, BangladeshSemantic proximity Read ↗

Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.Semantic proximity Read ↗

Prevalence and genetic variants of G6PD deficiency among malaria suspected patients in Shele and Lante Health Center, Southern EthiopiaSemantic proximity Read ↗

Glucose-6-phosphate Dehydrogenase (G6PD) A-Variant Frequency and Novel Polymorphism in Haiti.Semantic proximity Read ↗

Diagnostic accuracy of the Point-of-Care Standard G6PD test™ (SD Biosensor) for Glucose-6-phosphate dehydrogenase deficiency: a systematic review of the literatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.